Trial
NCT04121143
A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Plaque Psoriasis
Intervention
IL-17A Antagonist
Why stopped
sponsor's decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-23